Form 4 for NHI NATIONAL HEALTH INVESTORS INC
Accepted 2024-02-27 00:00:00 ET · period of report 2024-02-23 · accession 0001127602-24-007136 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-27 | 2024-02-23 | NHI | Spaid John L | CFO, EVP Fin | A - Grant | $0.00 | +3,000 | 18.3K | +20% | $0 |
| DM | 2024-02-27 | 2024-02-23 | NHI | Spaid John L | CFO, EVP Fin | A - Grant | $0.00 | +25.5K | 8,500 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-23 | A | A | 3,000 | $0.00 | 18,279.64 | D | — | — | (F1) These shares are restricted stock which vest 20% on each anniversary of the date of grant, starting February 23, 2025. |
| 2 | Derivative | Stock Option (Right to Buy) 2024 | 2024-02-23 | A | A | 8,500 | $0.00 | 8,500 | D | $57.76 · 2025-02-23 to 2029-02-23 | 8,500 Common Stock | |
| 3 | Derivative | Stock Option (Right to Buy) 2024 | 2024-02-23 | A | A | 8,500 | $0.00 | 8,500 | D | $57.76 · 2024-02-23 to 2029-02-23 | 8,500 Common Stock | |
| 4 | Derivative | Stock Option (Right to Buy) 2024 | 2024-02-23 | A | A | 8,500 | $0.00 | 8,500 | D | $57.76 · 2026-02-23 to 2029-02-23 | 8,500 Common Stock |